TARDBP and proteostasis deficiencies: We were particularly intrigued by the pTDP43-409 findings with both cognitive decline and hippocampal neurodegeneration suggesting that pTDP43-409 could be a promising blood biomarker for detecting TDP-43 clinical syndrome and perhaps the proteinopathy.